Literature DB >> 26887952

Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region.

Takayuki Sassa1, Taisuke Hirayama1, Akio Kihara2.   

Abstract

Ceramide and complex sphingolipids regulate important cellular functions including cell growth, apoptosis, and signaling. Dysregulation of sphingolipid metabolism leads to pathological consequences such as sphingolipidoses and insulin resistance. Ceramides in mammals vary greatly in their acyl-chain composition: six different ceramide synthase isozymes (CERS1-6) that exhibit distinct substrate specificity and tissue distribution account for this diversity. In the present study, we demonstrated that CERS2-6 were phosphorylated at the cytoplasmic C-terminal regions. Most of the phosphorylated residues conformed to a consensus motif for phosphorylation by casein kinase 2 (CK2), and treatment of cells with the CK2-specific inhibitor CX-4945 lowered the phosphorylation levels of CERS2, -4, -5, and -6. Phosphorylation of CERS2 was especially important for its catalytic activity, acting mainly by increasing itsVmaxvalue. Phosphorylation modestly increased the catalytic activities of CERS4 and -5 and mildly increased those of CERS3 and -6. Dephosphorylation of endogenous ceramide synthases in the mouse brain led to severely reduced activity toward the Cers2 substrates C22:0/C24:0-CoAs and modestly reduced activity toward the Cers5/6 substrate C16:0-CoA. These results suggest that the phosphorylation of ceramide synthases may be a key regulatory point in the control of the distribution and levels of sphingolipids of various acyl-chain lengths.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  casein kinase 2; ceramide synthase; fatty acid; lipid; protein phosphorylation; sphingolipid

Mesh:

Substances:

Year:  2016        PMID: 26887952      PMCID: PMC4817178          DOI: 10.1074/jbc.M115.695858

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Structural basis of CX-4945 binding to human protein kinase CK2.

Authors:  Andrew D Ferguson; Payal R Sheth; Andrea D Basso; Sunil Paliwal; Kimberly Gray; Thierry O Fischmann; Hung V Le
Journal:  FEBS Lett       Date:  2010-11-18       Impact factor: 4.124

2.  Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length.

Authors:  Katja-Martina Eckl; Rotem Tidhar; Holger Thiele; Vinzenz Oji; Ingrid Hausser; Susanne Brodesser; Marie-Luise Preil; Aysel Onal-Akan; Friedrich Stock; Dietmar Müller; Kerstin Becker; Ramona Casper; Gudrun Nürnberg; Janine Altmüller; Peter Nürnberg; Heiko Traupe; Anthony H Futerman; Hans C Hennies
Journal:  J Invest Dermatol       Date:  2013-04-02       Impact factor: 8.551

3.  Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy.

Authors:  Nicola Vanni; Floriana Fruscione; Edoardo Ferlazzo; Pasquale Striano; Angela Robbiano; Monica Traverso; Thomas Sander; Antonio Falace; Elisabetta Gazzerro; Placido Bramanti; Jacek Bielawski; Anna Fassio; Carlo Minetti; Pierre Genton; Federico Zara
Journal:  Ann Neurol       Date:  2014-05-20       Impact factor: 10.422

Review 4.  Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

Authors:  Maria Ruzzene; Lorenzo A Pinna
Journal:  Biochim Biophys Acta       Date:  2009-08-06

5.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

6.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

7.  A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation.

Authors:  Lihong Zhao; Stefka D Spassieva; Thomas J Jucius; Leonard D Shultz; H Elizabeth Shick; Wendy B Macklin; Yusuf A Hannun; Lina M Obeid; Susan L Ackerman
Journal:  PLoS Genet       Date:  2011-05-19       Impact factor: 5.917

Review 8.  Very long-chain fatty acids: elongation, physiology and related disorders.

Authors:  Akio Kihara
Journal:  J Biochem       Date:  2012-09-14       Impact factor: 3.387

Review 9.  Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.

Authors:  Akio Kihara; Susumu Mitsutake; Yukiko Mizutani; Yasuyuki Igarashi
Journal:  Prog Lipid Res       Date:  2007-03-14       Impact factor: 16.195

10.  Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis.

Authors:  Mika Ikeda; Yuki Kanao; Masao Yamanaka; Hiroko Sakuraba; Yukiko Mizutani; Yasuyuki Igarashi; Akio Kihara
Journal:  FEBS Lett       Date:  2008-06-11       Impact factor: 4.124

View more
  17 in total

Review 1.  Sphingolipids and their metabolism in physiology and disease.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

2.  Regulation of very-long acyl chain ceramide synthesis by acyl-CoA-binding protein.

Authors:  Natalia Santos Ferreira; Hanne Engelsby; Ditte Neess; Samuel L Kelly; Giora Volpert; Alfred H Merrill; Anthony H Futerman; Nils J Færgeman
Journal:  J Biol Chem       Date:  2017-03-19       Impact factor: 5.157

3.  Silencing of ceramide synthase 2 in hepatocytes modulates plasma ceramide biomarkers predictive of cardiovascular death.

Authors:  Steffen Schmidt; Sandra F Gallego; Iris Daphne Zelnik; Sergey Kovalchuk; Nanna Albæk; Richard R Sprenger; Charlotte Øverup; Yael Pewzner-Jung; Anthony H Futerman; Marie W Lindholm; Ole N Jensen; Christer S Ejsing
Journal:  Mol Ther       Date:  2021-08-14       Impact factor: 12.910

4.  Generation of a ceramide synthase 6 mouse lacking the DDRSDIE C-terminal motif.

Authors:  Jiyoon Kim; Yael Pewzner-Jung; Tammar Joseph; Shifra Ben-Dor; Anthony H Futerman
Journal:  PLoS One       Date:  2022-07-18       Impact factor: 3.752

5.  Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Authors:  Roger Sandhoff; Konrad Sandhoff
Journal:  Adv Neurobiol       Date:  2023

Review 6.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

7.  Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry.

Authors:  Justin M Snider; Ashley J Snider; Lina M Obeid; Chiara Luberto; Yusuf A Hannun
Journal:  J Lipid Res       Date:  2018-04-02       Impact factor: 5.922

Review 8.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis.

Authors:  Matthew J Scheffel; Kristi Helke; Ping Lu; Jacob S Bowers; Besim Ogretmen; Elizabeth Garrett-Mayer; Chrystal M Paulos; Christina Voelkel-Johnson
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

10.  Chronic Psychosocial Stress in Mice Is Associated With Increased Acid Sphingomyelinase Activity in Liver and Serum and With Hepatic C16:0-Ceramide Accumulation.

Authors:  Martin Reichel; Cosima Rhein; Lena M Hofmann; Juliana Monti; Lukasz Japtok; Dominik Langgartner; Andrea M Füchsl; Burkhard Kleuser; Erich Gulbins; Claus Hellerbrand; Stefan O Reber; Johannes Kornhuber
Journal:  Front Psychiatry       Date:  2018-10-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.